Evidence mapPaperPMID 40814123Full record

ArticleDiabetology & metabolic syndrome2025

Impaired central thyroid hormone sensitivity is associated with time in range in patients with type 2 diabetes mellitus in the euthyroid population.

Xu Jiang, Yu Gong, Guojuan Wang, Ying Li

Abstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xu JiangDepartment of Endocrinology and Metabolism, The Third Affiliated Hospital of Anhui Medical University (The First People's Hospital of Hefei), Hefei, Anhui, 230001, People's Republic of China.
Yu GongBengbu Medical University, Bengbu, Anhui, 233000, People's Republic of China.
Guojuan WangDepartment of Endocrinology and Metabolism, The Third Affiliated Hospital of Anhui Medical University (The First People's Hospital of Hefei), Hefei, Anhui, 230001, People's Republic of China.
Ying LiDepartment of Endocrinology and Metabolism, The Third Affiliated Hospital of Anhui Medical University (The First People's Hospital of Hefei), Hefei, Anhui, 230001, People's Republic of China. 474731880@qq.com.ORCID http://orcid.org/0000-0002-9205-7981

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the correlation between central thyroid hormone (TH) sensitivity and time in target glucose range (TIR) in patients with type 2 diabetes mellitus (T2DM).

methods483 enrolled inpatients with T2DM were collected with the continuous glucose monitoring (CGM) data and clinical characteristics. Thyroid stimulating hormone index (TSHI), thyrotropin-thyroxine resistance index (TT4RI) and thyroid feedback quantile index (TFQI) were calculated. The correlations between TSHI, TT4RI, TFQI and TIR were statistically analyzed.

resultsThe levels of FT4, TSHI, TT4RI and TFQI in TIR > 70% group were all higher compared with TIR ≤ 70% group (all P < 0.05). TSHI was positively correlated with TIR before the inflection point of 2.2 (β = 14.8, P < 0.001), and the correlation strengthened after there (β = 30.9, P < 0.001). TT4RI was positively correlated with TIR before the inflection point of 32 (β = 1.3, P < 0.001), and the correlation weakened after there (β = 0.7, P < 0.001). TFQI was not correlated with TIR before the inflection point of -0.6 (P = 0.302), but was positively correlated with TIR after there (β = 28.7, P < 0.001). For one-quartile increase in TSHI and TFQI, the odds of TIR-target (TIR > 70%) increased by 0.825 times and 1.3891 times respectively.

conclusionDecreased central TH sensitivity, namely increased TH resistance, is associated with elevated TIR, suggesting that central TH resistance maybe a protective factor for TIR.

Indexed as

Continuous glucose monitoringThyroid hormone sensitivityTime in target rangeType 2 diabetes mellitus

Identifiers

PMID40814123
PMCPMC12351832

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.